325 related articles for article (PubMed ID: 31706993)
21. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
Fride E; Ponde D; Breuer A; Hanus L
Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
[TBL] [Abstract][Full Text] [Related]
22. Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.
Miller LL; Picker MJ; Umberger MD; Schmidt KT; Dykstra LA
J Pharmacol Exp Ther; 2012 Jul; 342(1):177-87. PubMed ID: 22514333
[TBL] [Abstract][Full Text] [Related]
23. Anti-nociceptive and desensitizing effects of olvanil on capsaicin-induced thermal hyperalgesia in the rat.
Alsalem M; Millns P; Altarifi A; El-Salem K; Chapman V; Kendall DA
BMC Pharmacol Toxicol; 2016 Jul; 17(1):31. PubMed ID: 27439609
[TBL] [Abstract][Full Text] [Related]
24. Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors.
Jesus CHA; Redivo DDB; Gasparin AT; Sotomaior BB; de Carvalho MC; Genaro K; Zuardi AW; Hallak JEC; Crippa JA; Zanoveli JM; da Cunha JM
Brain Res; 2019 Jul; 1715():156-164. PubMed ID: 30898678
[TBL] [Abstract][Full Text] [Related]
25. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.
Campos AC; Ortega Z; Palazuelos J; Fogaça MV; Aguiar DC; Díaz-Alonso J; Ortega-Gutiérrez S; Vázquez-Villa H; Moreira FA; Guzmán M; Galve-Roperh I; Guimarães FS
Int J Neuropsychopharmacol; 2013 Jul; 16(6):1407-19. PubMed ID: 23298518
[TBL] [Abstract][Full Text] [Related]
26. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
[TBL] [Abstract][Full Text] [Related]
27. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
29. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.
De Gregorio D; McLaughlin RJ; Posa L; Ochoa-Sanchez R; Enns J; Lopez-Canul M; Aboud M; Maione S; Comai S; Gobbi G
Pain; 2019 Jan; 160(1):136-150. PubMed ID: 30157131
[TBL] [Abstract][Full Text] [Related]
30. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
[TBL] [Abstract][Full Text] [Related]
31. Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.
Rodríguez-Muñoz M; Onetti Y; Cortés-Montero E; Garzón J; Sánchez-Blázquez P
Mol Brain; 2018 Sep; 11(1):51. PubMed ID: 30223868
[TBL] [Abstract][Full Text] [Related]
32. 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.
Massi P; Valenti M; Vaccani A; Gasperi V; Perletti G; Marras E; Fezza F; Maccarrone M; Parolaro D
J Neurochem; 2008 Feb; 104(4):1091-100. PubMed ID: 18028339
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain.
Lomazzo E; Bindila L; Remmers F; Lerner R; Schwitter C; Hoheisel U; Lutz B
Neuropsychopharmacology; 2015 Jan; 40(2):488-501. PubMed ID: 25100669
[TBL] [Abstract][Full Text] [Related]
34. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy.
Uhelski ML; Khasabova IA; Simone DA
J Neurophysiol; 2015 Mar; 113(5):1501-10. PubMed ID: 25505113
[TBL] [Abstract][Full Text] [Related]
36. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Lötsch J; Weyer-Menkhoff I; Tegeder I
Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
[TBL] [Abstract][Full Text] [Related]
37. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
Hasanein P; Shahidi S; Komaki A; Mirazi N
Eur J Pharmacol; 2008 Sep; 591(1-3):132-5. PubMed ID: 18593578
[TBL] [Abstract][Full Text] [Related]
38. Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice.
Neelakantan H; Tallarida RJ; Reichenbach ZW; Tuma RF; Ward SJ; Walker EA
Behav Pharmacol; 2015 Apr; 26(3):304-14. PubMed ID: 25485642
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson's Disease.
Burgaz S; García C; Gómez-Cañas M; Rolland A; Muñoz E; Fernández-Ruiz J
Molecules; 2021 May; 26(11):. PubMed ID: 34071302
[TBL] [Abstract][Full Text] [Related]
40. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
